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Abstract
Introduction and hypothesis The use of synthetic mesh in transvaginal pelvic floor surgery has been subject to debate internationally.
Although mesh erosion appears to be less associated with an abdominal approach, the long-term outcome has not been studied
intensively. This study was set up to determine the long-term mesh erosion rate following abdominal pelvic reconstructive surgery.
Methods A prospective, observational cohort study was conducted in a tertiary care setting. All consecutive female patients who
underwent robot-assisted laparoscopic sacrocolpopexy and sacrocolporectopexy in 2011 and 2012 were included. Primary outcome
was mesh erosion. Preoperative and postoperative evaluation (6 weeks, 1 year, 5 years) with a clinical examination and questionnaire
regarding pelvic floor symptoms was performed. Mesh-related complications were assessed using a transparent vaginal speculum,
proctoscopy, and digital vaginal and rectal examination. Kaplan–Meier estimates were calculated for mesh erosion. A review of the
literature on mesh exposure after minimally invasive sacrocolpopexy was performed (≥12 months’ follow-up).
Results Ninety-six of the 130 patients included (73.8%) were clinically examined. Median follow-up time was 48.1 months
(range 36.0–62.1). Three mesh erosions were diagnosed (3.1%; Kaplan–Meier 4.9%, 95% confidence interval 0–11.0): one
bladder erosion for which mesh resection and an omental patch interposition were performed, and two asymptomatic vaginal
erosions (at 42.7 and 42.3 months) treated with estrogen cream in one. Additionally, 22 patients responded solely by question-
naire and/or telephone; none reported mesh-related complaints. The literature, mostly based on retrospective studies, described a
median mesh erosion rate of 1.9% (range 0–13.3%).
Conclusions The long-term rate of mesh erosion following an abdominally placed synthetic graft is low.
Keywords Erosion .Mesh exposure . Pelvic organ prolapse . Robotic . Sacrocolpopexy . Sacrocolporectopexy
Introduction
The use of synthetic mesh in pelvic floor surgery has been
subject to debate. In 2008 and 2011, the US Food and Drug
Administration (FDA) warned about the high rate of mesh-
related complications following transvaginal pelvic organ pro-
lapse repair [1]. The FDA warnings were underlined by a
systematic review reporting an incidence of mesh erosion of
10.3% (range 0–29.7%, n = 11.785) following transvaginal
pelvic organ prolapse repair in the first postoperative year
[2]. Recent literature on transvaginal repair has confirmed this
high incidence [3]. Transabdominal approaches for pelvic re-
constructive surgery are associated with a much lower inci-
dence of mesh erosion [1, 4]. However, most studies describ-
ing mesh erosion are retrospective with short-term follow-up.
Research focusing specifically on long-term mesh-related
morbidity is lacking.
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Minimally invasive sacrocolpopexy is currently the pre-
ferred treatment for apical prolapse, and ventral mesh
rectopexy has gained increasing worldwide acceptance for
rectal prolapse [5, 6]. More recently, the two abdominal pro-
cedures combined have been described and are being used as a
treatment for combined pathology [7, 8].
It is against this backdrop that we designed a study to
evaluate the long-term mesh erosion rate following robot-
assisted laparoscopic sacrocolpopexy (RSC) and robot-
assisted laparoscopic sacrocolporectopexy (RSCR). Second,
we performed a literature review on mesh erosion after mini-
mally invasive sacrocolpopexy with a minimum follow-up
duration of 12 months.
Materials and methods
Study design and participants
All consecutive female patients who underwent RSC or
RSCR at a tertiary referral center for pelvic floor disorders in
the Netherlands in 2011 and 2012 were prospectively includ-
ed. The set-up was an observational cohort study. The primary
outcome was long-term mesh erosion.
Inclusion and exclusion criteria
Inclusion criteria were patients with symptomatic vaginal
vault prolapse (simplified pelvic organ prolapse quantification
[simplified POP-Q] stage ≥2) and patients with additional
symptomatic internal/external rectal prolapse (Oxford
Grading System grade ≥ 3; an additional enterocele or
rectocele may be present). Exclusion criteria were conversion
to another procedure without mesh usage, poor health status
with inability to undergo general anesthesia, patients younger
than 18 years, ≥3 previous laparotomic surgeries, planned
pregnancy, known pelvic/abdominal malignancies. This study
was carried out in accordance with the ethical standards of the
Central Committee on Research Involving Human Subjects
and with the Declaration of Helsinki. Patients gave informed
consent before inclusion.
Clinical evaluation
Patients were clinically reviewed preoperatively and postopera-
tively at 6 weeks, 1 year, 5 years and in cases where complaints
occurred. Rectal prolapse was diagnosed and evaluated at follow-
up using theOxfordGrading System by proctoscopy and dynam-
icMRI [9]. The simplified POP-Qwas used to determine vaginal
prolapse [10]. At follow-up, all patients underwent a digital vag-
inal and rectal examination, a proctoscopy, and a vaginal specu-
lum examination to assess mesh-related complications. Both
proctoscope and speculum were transparent. Patients were
examined in the supine lithotomy position using leg supports,
both in rest and during maximal Valsalva. Clinical examination
was performed by an objective researcher (not blinded). If mesh-
related morbidity was suspected, a second examination by a gy-
necologist was performed to confirm the diagnosis.Mesh erosion
was graded according to the International Urogynaecological
Association (IUGA) and the International Continence Society
(ICS) joint terminology and category, time, and site (CTS) clas-
sification, although we used the term mesh erosion instead of
mesh exposure [11]. During every evaluation (pre- and postop-
eratively), patients received a surgical and urogynecological
questionnaire on paper, which included questions regarding
symptoms of bulge, micturition (Urinary Distress Inventory;
UDI-6), defecation (obstructive defecation and fecal inconti-
nence), and quality of life (Pelvic Floor Impact Questionnaire;
PFIQ-7) [12, 13]. In case patients declined clinical evaluation,
patients were invited to return the questionnaire by post.
Questions regarding mesh-related morbidity were asked postop-
eratively during the clinical evaluation or, if patients declined
examination, by telephone: Bvaginal/rectal bleeding or
discharge,^ Bvaginal/rectal pain,^ Bpelvic pain (either spontane-
ous or during physical activity),^ Brecurrent urinary tract
infection.^ Patients were considered lost to follow-up in cases
where no physical examination or no questionnairewas available.
Solely patients with a postoperative physical examination avail-
able were included in the analysis to determine the mesh erosion
rate.
Surgical technique
All procedures were performed using the da Vinci robot
(Intuitive Surgical, Sunnyvale, CA, USA) by three colon sur-
geons and two urogynecologists with ≥10 years’ experience.
Every patient received prophylactic intravenous antibiotics
(1,000 mg cefazolin and 500 mg metronidazole) 15 min prior
to incision. The RSC procedures, with or without supracervical
hysterectomy, were performed according to the technique de-
scribed by Clifton et al. [14]. RSC was performed solely by the
gynecologist. The technique of RSCR was performed jointly by
one colorectal and one urogynecological surgeon. The technique
of RSCR has been previously described by our study group [7].
All meshes (type 1, macroporous polypropylene, Prolene,
Ethicon Inc., Johnson & Johnson, Hamburg, Germany, weight
80–85 g/m2) were distally attached using non-absorbable sutures
(Ethibond; Ethicon, Johnson & Johnson, Hamburg, Germany)
and anchored proximally to the sacral promontory using titanium
tacks (Autosuture Protack 5 mm; Covidien, USA). Two meshes
were used, configured into a BY^ shape intracorporeally. The
peritoneum was approximated to cover the implant using a 23-
cmV-Loc suture (Covidien,Mansfield,MA, USA). The surgeon
performed a vaginal/rectal examination at the end of each proce-
dure to exclude a possible (suture) perforation of the vaginal and/
or rectal wall and to determine the correct position of the mesh.
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Review of the literature
To compare our mesh erosion rate with the literature, a literature
search was performed describing mesh erosion after minimally
invasive sacrocolpopexywith aminimal duration of follow-up of
12 months (Appendix A). Studies describing mesh erosion after
open/minimally invasive sacrocolporectopexy were described
separately (Appendix A).
Statistical analysis
Statistical Package for the Social Sciences, version 20.0 (IBM,
Armonk, NY, USA) was used for statistical analysis. Data are
presented as percentage, mean ± standard deviation (SD), and
median and range. Chi-squared test, Fisher’s exact test and
independent sample t test were used to compare variables
between groups for categorical and continuous data.
Because of differences in follow-up between patients, the
Kaplan–Meier method with 95% confidence intervals was
used to estimate the erosion rate at various time points. The




One hundred and thirty patients underwent surgery. One pro-
cedure (0.8%) was converted to vaginal prolapse surgery ow-
ing to a pre-sacral bleeding. This patient was excluded from
the study, since no mesh was placed. Twenty patients (15.4%)
were lost to follow-up and 11 patients (8.5%) solely responded
by questionnaire. In total, 96 patients (73.8%) were physically
examined in the outpatient clinic. The flow chart of patients
included is shown in Fig. 1.
Demographics and operative data
Fifty women (52.1%) underwent an RSC and 46 women
(47.9%) an RSCR (Table 1). RSC and RSCR were combined
with a concomitant supracervical hysterectomy in 36 (72%)
and in 25 (54.3%) cases respectively. Mean age and body
mass index of all patients were 62.3 ± 10.4 years and 26.1 ±
4.2 kg/m2 respectively. Two cases (2.1%) were converted to
an open procedure (extensive intra-abdominal adhesions n =
1; anesthesia-related issues n = 1). Intra-operative complica-
tions occurred in 3 (3.1%) patients; 2 small bladder perfora-
tions in the bladder dome and 1 minor serosal small bowel
lesion. No (mesh-related) postoperative complications were
observed in these specific patients. Median follow-up time
was 48.1 months (range 36.0–62.1).
Mesh-related complications
Three patients (3.1%) developed mesh erosion during follow-
up (Table 2). The accompanying actuarial erosion rates for the
total cohort were 0% after 1 year, 0% after 3 years, and 4.9%
after 5 years (95% confidence interval 0–11.0; Fig. 2; Kaplan–
Meier curve). The Kaplan–Meier estimates for RSC and
RSCR after 5 years were 5.3 (95% CI 0–12.4%) and 3.0
(95% CI 0–8.9) respectively. No significant difference be-
tween the two subgroups could be found (p = 0.808). The first
patient presented with pain, dysfunctional voiding, and recur-
rent urinary tract infections 45 months after RSC with
supracervical hysterectomy. A small defect of the posterior
wall of the bladder with mesh exposure was observed with
cystoscopy. The mesh was removed and an omental patch
interposition was performed. The second mesh erosion was
discovered during regular follow-up 42.7 months following
RSCR with supracervical hysterectomy. An asymptomatic
erosion was found in the posterior wall of the vagina for which
vaginal estrogen was prescribed. The third mesh erosion was
also asymptomatic and was found in the posterior wall of the
vagina at 42.3 months after RSC. Since the mesh exposure
was so small, expectant management was chosen. All three
patients who developed a mesh erosion had an extensive sur-
gical pelvic floor history (Table 2). Two of the three women
were postmenopausal. The three patients with mesh erosion
had some of the characteristics and recognized risk factors for
mesh erosion, including history of pelvic floor surgery (n = 3),
vaginal atrophy (n = 3), smoking (n = 1), sexual activity (n =
1), and age > 70 years (n = 2). During the intraoperative vag-
inal examination of one of these patients, a perforating suture
was removed, which may be another risk factor for the occur-
rence of mesh erosion.
Four (4.2%) other post-menopausal patients (mean age
70.3 ± 7.8 years), all with vaginal atrophy, experienced vagi-
nal discomfort examining the distal side of the mesh. Nomesh
erosion or other mucosal abnormalities were observed. One of
these patients developed postoperative new-onset
dyspareunia, but declined the use of vaginal estrogens, be-
cause of the sporadic occurrence of complaints. All four pa-
tients were offered vaginal estrogen therapy, only two (both
sexually active) patients accepted the prescription. No other
mesh-related morbidity was observed in the complete cohort.
Twenty-two patients were assessed solely by questionnaire,
none reported mesh-related complaints.
Overview of literature
Details of the literature search and a flow-chart of studies
included are presented in Appendix A. Sixty-five studies de-
scribed mesh erosion after laparoscopic sacrocolpopexy
(LSC) and/or RSC (Table 3).Most studies were of a retrospec-
tive design (73.8%). The literature on LSC and RSC shows
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erosion rates between 0 and 13.3% (range of number of pa-
tients included: 12–4,552; range of follow-up 12–72 months)
[3, 5, 15–77]. The articles that were included differed in their
methods and inclusion criteria. Some studies solely included
posthysterectomy patients. Other studies also included pa-
tients with their uterus still present, performing either a total
hysterectomy or supracervical hysterectomy. Furthermore,
different types of mesh were used throughout the studies.
Eighty-three percent of the articles reported an erosion per-
centage of ≤5% with an overall median erosion rate of 1.9%.
Six studies (9.2%) had a follow-up duration of more than
48 months [24, 34, 43, 51, 61, 74]. One of these six studies
included 391 patients. The authors reported mesh-related
complications requiring surgical intervention in 2.8% [51].
However, follow-up in this study, was carried out by tele-
phone interview and the numbers could therefore be
underestimated. The other five studies reported on 361 pa-
tients in total, with 15 mesh erosions (4.1%; range of mesh
erosion 2.9–7.8%). This is in line with the mesh erosion rate
found in our study. Dandolu et al. [3] described a large retro-
spective cohort of patients (N = 4,552, follow-up ≥2 years)
with an apical prolapse who underwent LSC. Mesh removal
or revision occurred in 52 patients (1.7%). One study by
Geller et al. [59] reported a mesh erosion rate of 13%. The
study included solely 15 patients, which could possibly ex-
plain the high erosion rate. Practically all erosions reported in
the literature were symptomatic. One study mentions asymp-
tomatic mesh erosion [62]. Three studies on sacrocolpopexy
using a light-weight mesh show an erosion percentage of 0%
after 12 months of follow-up [41, 68, 71].
Four studies described mesh erosion after open/minimal
invasive sacrocolporectopexy, varying from 2.0 to 5.4% (me-
dian range of follow-up 195 days to 64 months) [7, 8, 78, 79].
Only 1 of the 4 studies performed a rectal and vaginal exam-
ination after 12 months of follow-up and noted a 2% erosion
rate [7].
Discussion
Synthetic meshes have been used in pelvic reconstructive sur-
gery to reinforce weak or defective supportive tissue since
1959 [80]. The use of synthetic mesh potentially adds to the
complication profile and mesh-related morbidity can have a
considerable impact on the quality of life [81]. The introduc-
tion of transvaginal procedures showed a high risk of mesh-
related complications [1]. This study with long-term follow-
up shows that mesh-related morbidity following a minimally
invasive abdominal pelvic floor repair is low.
In total, there were 3 patients with a mesh erosion (3.1%), of
which 2were asymptomatic. Two of these 3 patients underwent a
concomitant supracervical hysterectomy. A total hysterectomy is
Fig. 1 Flowchart of patients included. aThe general practitioner was
contacted in the case of incorrect address details. bPatients had no
complaints and patients themselves judged an examination to be
unnecessary. cDue to natural causes. dTwo patients received a
colostomy and declined further participation: one because of therapy-
resistant fecal incontinence and extensive sphincter dysfunction, and
one because of disabling obstructed defecation. eQuestionnaires regard-
ing pelvic floor symptoms. The paper questionnaire was discussed during
consultation. Patients who were unable to attend or declined clinical
examination were asked to send back the questionnaire by post. These
patients and patients who were lost to follow-up were contacted addition-
ally by telephone to ask for specific anamnestic mesh-related morbidity.
fNo anamnestic mesh-related complaints. gPatients who could not be
reached: death (due to natural causes) n = 2, cognitive/physical condition
n = 3, untraceable n = 3, other n = 1. cond. condition FU follow-up, RSC
robot-assisted laparoscopic sacrocolpopexy, RSCR robot-assisted laparo-
scopic sacrocolporectopexy, QNR questionnaire
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associated with a four times higher risk of mesh erosion com-
pared with sacrocolpopexy without hysterectomy [82]. A subto-
tal hysterectomy, however, appears to generate mesh erosion
rates comparable with patients with a history of a hysterectomy
undergoing a sacrocolpopexy [82]. Other known predictors of
mesh erosion include the use of steroids, diabetes, level of sur-
geon experience, intra-abdominal adhesions, and postoperative
pelvic hematoma [3, 81–84].
In this study, a monofilament and macroporous (>75 μm,
type I) mesh was used, allowing host cell colonization with
Table 1 Patient demographics and operative data
Total (N = 96) RSC (n = 50)a RSCR (n = 46) p value
Mean age (SD) 62.3 (10.4) 62.4 (9.5) 62.2 (11.5) 0.922
Mean ASA classification (SD) 1.8 (0.5) 1.7 (0.5) 1.9 (0.5) 0.112
Mean parity (SD) 2.8 (1.0) 2.8 (1.1) 2.8 (1.0) 0.898
Mean BMI (SD) 26.1 (4.2) 25.9 (3.7) 26.3 (4.7) 0.683
Episiotomy (%) 51 (53.1) 29 (58.0) 22 (47.8) 0.318
Prolapse first degree relative (%) 35 (36.5) 20 (40.0) 15 (32.6) 0.648
Smoking (%) 23 (24.0) 12 (24.0) 11 (23.9) 0.957
Sexually active (%) 45 (46.9) 25 (50.0) 20 (43.5) 0.198
History (%)
TVT 5 (5.2) 1 (2.0) 4 (8.7) 0.195b
Burch colposuspension 1 (1.0) 1 (2.0) 0 1.000b
Hysterectomy 34 (35.4) 14 (28.0) 20 (43.5) 0.113
Sacrocolpopexy 1 (1.0) 1 (2.0) 0 1.000b
Anterior colporrhaphy 20 (20.8) 9 (18.0) 11 (23.9) 0.476
Posterior colporrhaphy 19 (19.8) 8 (16.0) 11 (23.9) 0.331
Rectopexy 2 (2.1) 1 (2.0) 1 (2.2) 1.000b
Perineal procedure 2 (2.1) 0 2 (4.3) 0.227b
Sphincter procedure 0 0 0 N/A
Hemorrhoidectomy 2 (2.1) 0 2 (4.3) 0.227b
Other abdominal surgery 32 (33.3) 15 (30.0) 17 (37.0) 0.470
Rectal prolapse (%)
ERP 4 (4.2) 0 4 (8.7) 0.049b
IRP or/and symptomatic rectocele 49 (51.0) 21 (42.0) 28 (60.9) 0.065
with enterocele 15 (15.6) 3 (6.0) 12 (26.1) 0.007
Simplified POP-Q, mean (SD)
POP-Q Ba 2.4 (1.0) 2.6 (0.9) 2.4 (0.9) 0.947
POP-Q Bp 1.9 (1.0) 1.9 (1.0) 2.2 (1.0) 0.149
POP-Q C 2.5 (1.0) 2.9 (0.9) 2.3 (1.0) 0.021
POP-Q D 2.0 (1.0) 2.4 (1.0) 2.2 (1.0) 0.273
Concomitant supracervical hysterectomy (%) 61 (63.5) 36 (72.0) 25 (54.3) 0.073
Conversion (%) 2 (2.1) 1 (2.0) 1 (2.2) 1.000b
Intra-operative complications (%) 3 (3.1) 0 3 (6.5) 0.106
Mean LOS, nights (SD) 2.8 (1.2) 2.3 (0.9) 3.4 (1.2) <0.0005
Early postoperative complications (%)
CD grade ≤ 2 2 (2.1) 2 (4.0) 0 0.496b
CD grade ≥ 3 1 (1.0) 1 (2.0) 0 1.000b
Mesh erosion (%) 3 (3.1) 2 (4.0) 1 (2.2) 1.000b
Postoperative in-hospital mortality (%) 0 0 0 N/A
RSC robot-assisted laparoscopic sacrocolpopexy, RSCR robot-assisted laparoscopic sacrocolporectopexy, simplified POP-Q simplified pelvic organ
prolapse quantification, SD standard deviation, ASA American Society of Anesthesiologists, BMI body mass index, TVT tension-free vaginal tape, N/A
not applicable, ERP external rectal prolapse, IRP internal rectal prolapse, symptomatic, LOS length of hospital stay, CD Clavien–Dindo classification
a Two RSCs were combined with a TVT
b Fisher’s exact test
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collagen deposition, angiogenesis, and infiltration of leuko-
cytes, resulting in good support and a reduced risk of infection
[28]. Research showed that synthetic meshes with smaller
pores (type II and III) are associated with a higher erosion rate
[81, 85]. It has been suggested that lightweight meshes might
be less prone to erosion, but may have a higher recurrence rate
than heavy-weight grafts. Three studies show a 0% mesh ero-
sion rate one year after the use of light-weight mesh [41, 68,
71]. Studies with longer follow-up or comparative studies for
an abdominal prolapse repair, however, do not exist. Data on
mesh usage with abdominal hernia repairs suggests an impact
of the weight of the mesh, but the optimal balance between
weight and porosity is unknown [86]. No significant differ-
ence is observed between synthetic and biological mesh in
mesh-related complications [85, 87–89]. Evidence suggests,
however, that recurrence rates are higher following a repair
with biological mesh compared with synthetic mesh [6, 29,
89, 90]. To reduce the risk of mesh erosion, we administered
preoperative antibiotics, dissected meticulously with strict
monitoring of hemostasis to prevent a hematoma, attached
the (type I) mesh, and closed the incised peritoneum over
the mesh. But considering the numerous risk factors and pre-
vention strategies, the occurrence of mesh erosion presumably
has a multifactorial origin. Mesh erosion after laparoscopic
ventral rectopexy has been described to occur in the rectum,
vagina or bladder, and strictures or rectovaginal fistulas have
also been described [91]. In this study, we have not found
rectal mesh erosion, nor did we have patients with symptoms
suggesting fistulas or strictures.
Four (4.2%) patients in this study experienced vaginal dis-
comfort during speculum examination. Two of these 4 patients
(both sexually active) occasionally experienced vaginal dis-
comfort in daily life. The possibility of vaginal discomfort,
probably due to vaginal atrophy and reduced elasticity of the
vaginal wall caused by the mesh, should be considered in the
decision to offer pelvic reconstructive surgery using mesh in
older sexually active females. Both the rectum and the vagina
were examined in this study, but only vaginal erosions were
diagnosed. The most probable explanation for this difference
is vaginal atrophy, which increases with age. In order to obvi-
ate this, surgeons could consider prescribing vaginal estrogen
cream pre- and postoperatively.
The erosion rates in the literature are in line with our ero-
sion rates. However, the majority of the studies in the literature
were retrospective and lacked a systematic follow-up with a
rectal and vaginal examination. Furthermore, this study
proves that mesh erosion can also occur asymptomatically.
The clinical significance of an asymptomatic mesh erosion
is, however, unclear. Only the patient with symptomatic mesh
erosion underwent surgical intervention in our series. Because
of the difference in methods and follow-up, the retrospective
design and the lack of mentioning asymptomatic erosions, it is
likely that erosion rates are underestimated in the current lit-
erature. We believe that the erosion rate in this study ap-
proaches the true rate.
The strong points of this study were its prospective nature,
with the use of validated questionnaires and standardized




















4B/T4/S3 < 1 45.0 Mesh resection and omental
patch interposition









2A/T4/S1 1 42.7 Vaginal estrogen therapy
twice a week





2A/T4/S1 < 1 42.3 Expectant management
ASA American Society of Anesthesiologists CTS category (C), time (T) and site (S)
Fig. 2 Kaplan–Meier curve of mesh erosion. Kaplan–Meier curve for
mesh erosion after RSC and RSCR (straight line). Dotted gray lines
represent upper and lower 95% confidence intervals. The duration of
event-free survival was measured from the date of surgery to the time
of the event (complete) or the last follow-up (censored).
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Table 3 Mesh erosion following minimally invasive sacrocolpopexy with synthetic mesh (≥ 12 months of follow-up)











Paraiso et al. [5] 33 L, 35 R PP, 1 Only vaginal 12 0 L, 2f (5.7) R 0 L, 2f (5.7) R
Chan et al. [15] 20 L, 16 R PP, 1 Only vaginal 39 L, 16 R 0 L, 0 R 0 L, 0 R
Tan-Kim et al. [16] 58 L, 41 R PP, 1 Only vaginal 12 L, 19 R 2 (3.6) L, 2 (4.9) R 2 (3.6) L, 2 (4.9) R
Seror et al. [17] 47 L, 20 R PP, 1 Only vaginal 18 L, 15 R 1 (2.1) L, 0 R 1 (2.1) L, 0 R
Joubert et al. [18] 39 L, 17 R PP, 1/PE, 3 Only vaginal 14.9 L, 12 R 2 (5.1) L, 0 R 2 (5.1) L, 0 R
Tan-Kim et al. [19] 32 L, 32 R PP, 1 Only vaginal 12 1 (3.1) L, 2 (6.3) R 1 (3.1) L, 1 (3.1) R
Kenton et al. [20] 33 L, 33R PP, 1 Only vaginal 12 0 0
Laparoscopic
Antiphon et al. [21] 104 PE, 3 Only vaginal 17 2 (1.9) 0
Gadonneix et al. [22] 46 PE, 3 Only vaginal 24 0 0
Paraiso et al. [23] 56 PP, 1 n/d 13.5d 2 (3.6) 2 (3.6)
Ross and Preston [24] 51 PP, 1 Only vaginal 60 6 (11.8) 4 (7.8)
Rozet et al. [25] 325 PE, 3 Only vaginal 14.5d 8g (2.5) 3 (0.9)
Agarwala et al. [26] 72 PP, 1 Only vaginal 24 1 (1.4) 0
Rivoire et al. [27] 108 PP, 1 Only vaginal 33.7d 9 (8.3) 7 (6.5)
Stepanian et al. [28] 402 PP, 1 n/d 12 12 (3.0) 5 (1.2)
Deprest et al. [29] 104a PP, 1a Only vaginal 33d 12 (11.5) 8 (7.7)i
Granese et al. [30] 165 PP, 1 Yes, both 43 7 (4.2)h 1 (0.6)
Loffeld et al. [31] 20 PP, 1 Only vaginal 45d 1 (5.0) 1 (5.0)
North et al. [32] 22 PP, 1 Only vaginal 27.5d 1 (4.5) 1 (4.5)
Akladios et al. [33] 48 PP, 1 Only vaginal 15.8d 1 (2.2) 1 (2.2)
Sabbagh et al. [34] 132 PP, 1 Only vaginal 60 6 (4.5) 5 (3.8)
Maher et al. [35] 53 PP, 1 Only vaginal 24d 1 (1.9) 1 (1.9)
Sergent et al. [36] 116 PE, 3 Only vaginal 34.2 5 (4.3) 4 (3.4)
Perez et al. [37] 85 PE, 3 Only vaginal 12 5 (5.9) 3 (3.5)
Price et al. [38] 84 PP, 1 Only vaginal 24d 5 (6.0) 5 (6.0)j
Freeman et al. [39] 23 PP, 1 Only vaginal 12 0 0
Leruth et al. [40] 55 PE, 3 Only vaginal 25d 0 0
Liu et al. [41] 39 PP, 1 Only vaginal 12 0 0
Park et al. [42] 54 PP, 1 Only vaginal 29.7d 3 (5.6) 3 (5.6)
Sarlos et al. [43] 68 PP, 1 Only vaginal 60d 2 (2.9) 2 (2.9)
El Hamamsy and Fayyad [44] 220 PP, 1 Only vaginal 12 2 (0.9) 2 (0.9)
Estrade et al. [45] 35 PE, 3 Only vaginal 13.2 1 (2.9) 1 (2.9)
Gracia et al. [46] 30 PP, 1 Only vaginal 12 0 0
Vieillefosse et al. [47] 100 PP, 1/PE, 3 Only vaginal 23.6 2 (2.0) 2 (2.0)
Costantini et al. [48] 60 PP, 1 Only vaginal 41.7d 3 (5.0) 3 (5.0)
Dandolu et al. [3] 4,552 n/d n/a 24 52 (1.7) 52 (1.7)
Liang et al. [49] 30 PP, 1 Only vaginal 36 3 (10) 3 (10)
Lizee et al. [50] 60 PE, 3 Only vaginal 27 1 (1.7) 1 (1.7)
Vandendriessche et al. [51] 391b PP, 1/PE, 3 No, telephone FU 53.3 11 (2.8) 7 (1.8)
Zebede et al. [52] 144 PP, 1 Only vaginal 21 4 (2.8) 0
Pan et al. [53] 99 PP, 1 Only vaginal 33d 0 0
Chen and Hua [54] 102 PP, 1 Only vaginal 24 1 (1.0) 1 (1.0)
Robotic
Elliott et al. [55] 42 PP, 1 Only vaginal 36d 3 (7.1) 2 (4.8)
Benson et al. [56] 33 PP, 1 n/d 20.7–38.4e 2 (6.1) 0
Shveiky et al. [57] 17 PP, 1 Only vaginal 12.3 0 0
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follow-up examinations to confirm our findings. Loss to
follow-up was low considering the long duration of the study
and reasons for loss to follow-up were known. Furthermore,
solely type 1 mesh was used throughout this study, minimiz-
ing heterogeneity and variability. Another strong point is that
it reports not only on sacrocolpopexy, but also on combined
sacrocolporectopexy, making the results more widely
applicable.
The most important limitation of this study is that all pa-
tients were treated in a single tertiary referral hospital for pel-
vic floor disorders. Some of the patients had complex pelvic
floor disorders and/or an extensive history of pelvic floor sur-
gery, therefore limiting the generalizability of the results. In
addition, 26.1% of all invited patients were not physically
examined for various reasons, and therefore bias may have
occurred. These patients were, however, assessed using a
questionnaire specifically assessing erosion-related com-
plaints. We aimed for a 5-year follow-up; however, the
follow-up time ended up being 48.1 months. Most patients
were examined between 43 and 54 months (interquartile
range), therefore limiting our Kaplan–Meier estimates at the
exact time point of 60 months. We added 95% confidence
intervals to make our results more accurate and interpretable
with the wider range of follow-up. Results of the Kaplan-
Meier curve should therefore be interpret with caution.
Another limitation is that we did not perform a power analysis.
This study was set up as an observational cohort study, and
our hypothesis, based on literature, was to find a low inci-
dence, and significant prognostic factors were therefore not
expected. In our literature review, studies with different
Table 3 (continued)










Xylinas et al. [58] 12 PP, 1 n/d 19.1 0 0
Geller et al. [59] 15 PP, 1 Only vaginal 14.8d 2 (13.3) 2 (13.3)
Moreno Sierra et al. [60] 31 PP, 1 Only vaginal 24.5d 1 (3.2) 0
Shimko et al. [61] 40 PP, 1 Only vaginal 62 2 (5.0) 2 (5.0)
Geller et al. [62] 23 PP, 1 Only vaginal 44.2d 2 (8.7) 2 (8.7)
Göçmen et al. [63] 12 PP, 1 n/d 12 0 0
Mourik et al. [64] 50c PP, 1 Only vaginal 16 1 (2.0) 0
Siddiqui et al. [65] 70 PP, 1 Only vaginal 18.3d 3 (4.3) 3 (4.3)
Belsante et al. [66] 35 PP, 1 Only vaginal 28 1 (2.9) 1 (2.9)
Louis-Sylvestre and Herry [67] 90 PE, 3 n/d 15.6d 1 (1.1) 1 (1.1)
Salamon et al. [68] 118 PP, 1 Only vaginal 12 0 0
Barboglio et al. [69] 127 PP, 1 Only vaginal 12 3 (2.4) 3 (2.4)
Borahay et al. [70] 20 PP, 1 Only vaginal 17.3d 0 0
Culligan et al. [71] 143 PP, 1 Only vaginal 12 0 0
Ploumidis et al. [72] 95 PP, 1 Only vaginal 34.8 1 (1.1) 1 (1.1)
Jambusaria et al. [73] 30 PP, 1 Only vaginal 12 1 (3.3) 1 (3.3)
Linder et al. [74] 70 PP, 1 n/d 72 2 (2.9) 2 (2.9)
Myers et al. [75] 83 PP, 1 Only vaginal 12.8 4 (4.8) 4 (4.8)
Prendergast et al. [76] 33 PP, 1 Only vaginal 12 2 (6.1) 2 (6.1)
Linder et al. [77] 132 PP, 1 Only vaginal 33 8 (6.1) 8 (6.1)
L laparoscopic, R robot, PP polypropylene, PE polyester, n/d not described, n/a not applicable, FU follow-up
a 39 with porcine dermis, 65 with PP
b Long-term follow-up performed with telephone/postal questionnaire
c All procedures were robot-assisted laparoscopic sacrohysteropexy
dMean instead of median
e Patients with laparoscopic sacrocolpopexy: mean FU 38.4 months, patients with laparoscopic sacrocolpopexy and hysterectomy: mean FU 20.7
f One erosion was from a tension-free vaginal tape
g Two patients with an additional tension-free vaginal tape had urinary retention requiring section of the tape
h Includes detachment of the mesh
i Two after sacrocolpopexy with xenograft, 6 after sacrocolpopexy with PP
j Four out of 5 were suture erosions
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inclusion criteria and methods were included. This impaired
the homogeneity of the literature results.
Mesh-related morbidity is an important issue because of
the potential impact on the quality of life, the widespread
use of mesh and the global attention to the topic. In recent
years, the public opinion has turned fiercely against the use
of synthetic grafts. Fear of mesh-related morbidity is resulting
in under-treatment of all serious, disabling pelvic floor disor-
ders. The results of this study and the literature review dem-
onstrate that abdominally placed synthetic meshes for pelvic
reconstructive surgery has a low complication rate in the long-
term. This is an encouraging finding for patients, doctors, and
governmental institutions, in a field marked by a lack of
knowledge about the use of mesh. Surgeons using synthetic
mesh for pelvic floor repair are encouraged to perform focused
and meticulous examinations looking for mesh erosion in the
long-term to confirm these results.
Acknowledgements The authors thank Marlies Jansen for the language
revision and Corinne Verduijn-Staal for study coordination.
Compliance with ethical standards
Conflicts of interest IAMJ Broeders, SE Schraffordt Koops are proctors
for Intuitive Surgical. The remaining authors declare that they have no
conflicts of interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. FDA. Food and Drug Administration. FDA safety communication:
Urogynecologic surgical mesh: update on the safety and effective-
ness of transvaginal placement for pelvic organ prolapse. Rev lit
arts am. Available at: http://www.fda.gov/downloads/medical.
2011. Accessed 28 November 2016.
2. Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers
RG, for the systematic review group of the Society of Gynecologic
Surgeons. Incidence andmanagement of graft erosion, wound gran-
ulation, and dyspareunia following vaginal prolapse repair with
graft materials: a systematic review. Int Urogynecol J. 2011;22:
789–98.
3. Dandolu V, Akiyama M, Allenback G, Pathak P. Mesh complica-
tions and failure rates after transvaginal mesh repair compared with
abdominal or laparoscopic sacrocolpopexy and to native tissue re-
pair in treating apical prolapse. Int Urogynecol J. 2016;28:215–22.
4. SeratiM, Bogani G, Sorice P, Braga A, TorellaM, Salvatore S, et al.
Robot-assisted sacrocolpopexy for pelvic organ prolapse: a system-
atic review and meta-analysis of comparative studies. Eur Urol.
2014;66:303–18.
5. Paraiso MFR, Jelovsek JE, Frick A, Chen CCG, Barber MD.
Laparoscopic compared with robotic sacrocolpopexy for vaginal
prolapse: a randomized controlled trial. Obstet Gynecol.
2011;118:1005–13.
6. Van Iersel JJ, Paulides TJC, Verheijen PM, Lumley JW, Broeders
IAMJ, Consten ECJ. Current status of laparoscopic and robotic
ventral mesh rectopexy for external and internal rectal prolapse.
World J Gastroenterol. 2016;22:4977–87.
7. Van Iersel JJ, de Witte CJ, Verheijen PM, Broeders IAMJ, Lenters
E, Consten ECJ, et al. Robot-assisted sacrocolporectopexy for
multicompartment prolapse of the pelvic floor: a prospective cohort
study evaluating functional and sexual outcome. Dis Colon
Rectum. 2016;59:968–74.
8. Unger CA, Paraiso MFR, Jelovsek JE, Barber MD, Ridgeway B.
Perioperative adverse events after minimally invasive abdominal
sacrocolpopexy. Am J Obstet Gynecol. 2014;211:547.e1–8.
9. Wijffels NA, Collinson R, Cunningham C, Lindsey I. What is the
natural history of internal rectal prolapse? Colorectal Dis. 2010;12:
822–30.
10. Swift S, Morris S, McKinnie V, Freeman R, Petri E, Scotti RJ, et al.
Validation of a simplified technique for using the POPQ pelvic
organ prolapse classification system. Int Urogynecol J Pelvic
Floor Dysfunct. 2006;17:615–20.
11. Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW,
Deprest J, et al. An International Urogynecological Association
(IUGA)/International Continence Society (ICS) joint terminology
and classification of the complications related directly to the inser-
tion of prostheses (meshes, implants, tapes) and grafts in female
pelvic floor surgery. Int Urogynecol J. 2011;22:3–15.
12. Utomo E, Korfage IJ, Wildhagen MF, Steensma AB, Bangma CH,
Blok BFM. Validation of the urogenital distress inventory (UDI-6)
and incontinence impact questionnaire (IIQ-7) in a Dutch popula-
tion. Neurourol Urodyn. 2015;34(1):24–31.
13. Utomo E, Blok BF, Steensma AB, Korfage IJ. Validation of the
pelvic floor distress inventory (PFDI-20) and pelvic floor impact
questionnaire (PFIQ-7) in a Dutch population. Int Urogynecol J.
2014;25:531–44. https://doi.org/10.1007/s00192-013-2263-z.
14. Clifton MM, Pizarro-Berdichevsky J, Goldman HB. Robotic female
pelvic floor reconstruction: a review. Urology. 2016;91:33–40.
15. Chan SSC, Pang SMW, Cheung TH, Cheung RYK, Chung TKH.
Laparoscopic sacrocolpopexy f or the treatment of vaginal vault
prolapse: with or without robotic assistance. Hong Kong Med J.
2011;17:54–60.
16. Tan-Kim J, Menefee SA, Luber KM, Nager CW, Lukacz ES.
Robotic-assisted and laparoscopic sacrocolpopexy: comparing op-
erative times, costs and outcomes. Female Pelvic Med Reconstr
Surg. 2011;17:44–9.
17. Seror J, Yates DR, Seringe E, Vaessen C, Bitker M-O, Chartier-
Kastler E, et al. Prospective comparison of short-term functional
outcomes obtained after pure laparoscopic and robot-assisted lapa-
roscopic sacrocolpopexy. World J Urol. 2013;30:393–8.
18. Joubert M, Thubert T, Lefranc J-P, Vaessen C, Chartier-Kastler E,
Deffieux X, et al. Comparison of functional outcomes with purely
laparoscopic sacrocolpopexy and robot-assisted sacrocolpopexy in
obese women. Prog Urol. 2014;24:1106–13.
19. Tan-Kim J, Nager CW, Grimes CL, Luber KM, Lukacz ES, Brown
HW, et al. A randomized trial of vaginal mesh attachment tech-
niques for minimally invasive sacrocolpopexy. Int Urogynecol J.
2015;26:649–56.
20. Kenton K, Mueller ER, Tarney C, Bresee C, Anger JT. One-year
outcomes after minimally invasive sacrocolpopexy. Female Pelvic
Med Reconstr Surg. 2016;22:382–4.
21. Antiphon P, Elard S, Benyoussef A, FofanaM, Yiou R, GettmanM,
et al. Laparoscopic promontory sacral colpopexy: is the posterior,
recto-vaginal, mesh mandatory? Eur Urol. 2004;45:655–61.
22. Gadonneix P, Ercoli A, Salet-Lizée D, Cotelle O, Bolner B, Van
Den Akker M, et al. Laparoscopic sacrocolpopexy with two sepa-
rate meshes along the anterior and posterior vaginal walls for
1431Int Urogynecol J (2020) 31:1423–1433
multicompartment pelvic organ prolapse. J Am Assoc Gynecol
Laparosc. 2004;11:29–35.
23. Paraiso MFR, Walters MD, Rackley RR, Melek S, Hugney C.
Laparoscopic and abdominal sacral colpopexies: a comparative co-
hort study. Am J Obstet Gynecol. 2005;192:1752–8.
24. Ross JW, Preston M. Laparoscopic sacrocolpopexy for severe vag-
inal vault prolapse: five-year outcome. J Minim Invasive Gynecol.
2005;12:221–6.
25. Rozet F, Mandron E, Arroyo C, Andrews H, Cathelineau X,
Mombet A, et al. Laparoscopic sacral colpopexy approach for
genito-urinary prolapse: experience with 363 cases. Eur Urol.
2005;47:230–6.
26. Agarwala N, Hasiak N, Shade M. Laparoscopic sacral colpopexy
with Gynemesh as graft material—experience and results. J Minim
Invasive Gynecol. 2007;14:577–83.
27. Rivoire C, Botchorishvili R, Canis M, Jardon M, Rabischong B,
Wattiez A, et al. Complete laparoscopic treatment of genital pro-
lapse with meshes including vaginal promontofixation and anterior
repair: a series of 138 patients. J Minim Invasive Gynecol. 2007;14:
712–8.
28. Stepanian AA, Miklos JR, Moore RD, Mattox TF. Risk of mesh
extrusion and other mesh-related complications after laparoscopic
sacral colpopexy with or without concurrent laparoscopic-assisted
vaginal hysterectomy: experience of 402 patients. J Minim Invasive
Gynecol. 2008;15:188–96.
29. Deprest J, De Ridder D, Roovers J-P, Werbrouck E, Coremans G,
Claerhout F. Medium term outcome of laparoscopic
sacrocolpopexy with xenografts compared to synthetic grafts. J
Urol. 2009;182:2362–8.
30. Granese R, Candiani M, Perino A, Romano F, Cucinella G.
Laparoscopic sacrocolpopexy in the treatment of vaginal vault pro-
lapse: 8 years experience. Eur J Obstet Gynecol Reprod Biol.
2009;146:227–31.
31. Loffeld CJW, Thijs S, Mol BW, Bongers MY, Roovers J-PWR.
Laparoscopic sacrocolpopexy: a comparison of Prolene and
Tutoplast mesh. Acta Obstet Gynecol Scand. 2009;88:826–30.
32. North CE, Ali-Ross NS, Smith ARB, Reid FM. A prospective study
of laparoscopic sacrocolpopexy for the management of pelvic organ
prolapse. BJOG. 2009;116:1251–7.
33. Akladios CY, Dautun D, Saussine C, Baldauf JJ, Mathelin C,
Wattiez A. Laparoscopic sacrocolpopexy for female genital organ
prolapse: establishment of a learning curve. Eur J Obstet Gynecol
Reprod Biol. 2010;149:218–21.
34. Sabbagh R, Mandron E, Piussan J, Brychaert PE, Tu LM. Long-
term anatomical and functional results of laparoscopic
promontofixation for pelvic organ prolapse. BJU Int. 2010;106:
861–6.
35. Maher CF, Feiner B, DeCuyper EM, Nichlos CJ, Hickey KV,
O’Rourke P. Laparoscopic sacral colpopexy versus total vaginal
mesh for vaginal vault prolapse: a randomized trial. Am J Obstet
Gynecol. 2011;204:360.e1–7.
36. Sergent F, Resch B, Loisel C, Bisson V, Schaal J-P, Marpeau L.
Mid-term outcome of laparoscopic sacrocolpopexy with anterior
and posterior polyester mesh for treatment of genito-urinary pro-
lapse. Eur J Obstet Gynecol Reprod Biol. 2011;156:217–22.
37. Perez T, Crochet P, Descargues G, Tribondeau P, Soffray F,
Gadonneix P, et al. Laparoscopic sacrocolpopexy for management
of pelvic organ prolapse enhances quality of life at one year: a
prospective observational study. J Minim Invasive Gynecol.
2011;18:747–54.
38. Price N, Slack A, Jackson SR. Laparoscopic sacrocolpopexy: an
observational study of functional and anatomical outcomes. Int
Urogynecol J. 2011;22:77–82.
39. Freeman RM, Pantazis K, Thomson A, Frappell J, Bombieri L,
Moran P, et al. A randomised controlled trial of abdominal versus
laparoscopic sacrocolpopexy for the treatment of post-
hysterectomy vaginal vault prolapse: LAS study. Int Urogynecol
J. 2013;24:377–84.
40. Leruth J, Fillet M, Waltregny D. Incidence and risk factors of post-
operative stress urinary incontinence following laparoscopic
sacrocolpopexy in patients with negative preoperative prolapse re-
duction stress testing. Int Urogynecol J. 2013;24:485–91.
41. Liu C-K, Tsai C-P, ChouM-M, Shen PS, Chen GD, Hung YC, et al.
A comparative study of laparoscopic sacrocolpopexy and total vag-
inal mesh procedure using lightweight polypropylene meshes for
prolapse repair. Taiwan J Obstet Gynecol. 2014;53:552–8.
42. Park YH, Yang SC, Park ST, Park SH, Kim HB. Laparoscopic
reconstructive surgery is superior to vaginal reconstruction in the
pelvic organ prolapse. Int J Med Sci. 2014;11(11):1082–8.
43. Sarlos D, Kots L, Ryu G, Schaer G. Long-term follow-up of lapa-
roscopic sacrocolpopexy. Int Urogynecol J. 2014;25:1207–12.
44. El HamamsyD, Fayyad AM. New onset stress urinary incontinence
following laparoscopic sacrocolpopexy and its relation to anatom-
ical outcomes. Int Urogynecol J. 2015;26:1041–5.
45. Estrade J-P, Gurriet B, Franquebalme J-P, Chinchole J-M,
Glowaczower E, Ferry C, et al. Laparoscopic sacrocolpopexy with
a vaginal prosthetic adhesive. Gynecol Obstet Fertil. 2015;43:419–
23.
46. Gracia M, Perello M, Bataller E, Espuna M, Parellada M, Genis D,
et al. Comparison between laparoscopic sacral hysteropexy and
subtotal hysterectomy plus cervicopexy in pelvic organ prolapse:
a pilot study. Neurourol Urodyn. 2015;34:654–8.
47. Vieillefosse S, Thubert T, Dache A, Hermieu J-F, Deffieux X.
Satisfaction, quality of life and lumbar pain following laparoscopic
sacrocolpopexy: suture vs. tackers. Eur J Obstet Gynecol Reprod
Biol. 2015;187:51–6.
48. Costantini E, Mearini L, Lazzeri M, Bini V, Nunzi E, di Biase M,
et al. Laparoscopic versus abdominal Sacrocolpopexy: a random-
ized, controlled trial. J Urol. 2016;196:159–65.
49. Liang S, Zhu L, Song X, Xu T, Sun Z, Lang J. Long-term outcomes
ofmodified laparoscopic sacrocolpopexy for advanced pelvic organ
prolapse: a 3-year prospective study. Menopause. 2016;23:765–70.
50. Lizee D, Campagna G, Morciano A, Panico G, Ercoli A,
Gadonneix P. Laparoscopic sacral colpopexy: how to place the
posterior mesh into rectovaginal space? Neurourol Urodyn.
2016;9999:1–6.
51. Vandendriessche D, Sussfeld J, Giraudet G, Lucot J-P, Behal H,
Cosson M. Complications and reoperations after laparoscopic
sacrocolpopexy with a mean follow-up of 4 years. Int Urogynecol
J. 2016;28:231–9.
52. Zebede S, Dawood A, Alarab M, Drutz H, Lovatsis D. A stream-
lined surgical approach to laparoscopic Sacrocolpopexy for post-
hysterectomy vault prolapse. J Obstet Gynaecol Can. 2016;38:446–
52.
53. Pan K, Cao L, Ryan NA, Wang Y, Xu H. Laparoscopic sacral
hysteropexy versus laparoscopic sacrocolpopexy with hysterecto-
my for pelvic organ prolapse. Int Urogynecol J. 2016;27:93–101.
54. Chen Y, Hua K. Medium-term outcomes of laparoscopic
sacrocolpopexy or sacrohysteropexy versus vaginal sacrospinous
ligament fixation for middle compartment prolapse. Int J Gynecol
Obstet. 2017;137(2):164–9.
55. Elliott DS, Siddiqui SA, ChowGK. Assessment of the durability of
robot-assisted laparoscopic sacrocolpopexy for treatment of vaginal
vault prolapse. J Robot Surg. 2007;1:163–8.
56. Benson AD, Kramer BA, Wayment RO, Schwartz BF.
Supracervical robotic-assisted laparoscopic sacrocolpopexy for
pelvic organ prolapse. JSLS. 2010;14:525–30.
57. Shveiky D, Iglesia CB, Sokol AI, Kudish BI, Gutman RE. Robotic
sacrocolpopexy versus vaginal colpopexy with mesh: choosing the
right surgery for anterior and apical prolapse. Female Pelvic Med
Reconstr Surg. 2010;16:121–7.
1432 Int Urogynecol J (2020) 31:1423–1433
58. Xylinas E, Ouzaid I, DurandX, Ploussard G, Salomon L, Gillion N,
et al. Robot-assisted laparoscopic sacral colpopexy: initial experi-
ence in a high-volume laparoscopic reference center. J Endourol.
2010;24:1985–9.
59. Geller EJ, Parnell BA, Dunivan GC. Pelvic floor function before
and after robotic sacrocolpopexy: one-year outcomes. J Minim
Invasive Gynecol. 2011;18:322–7.
60. Moreno Sierra J, Ortiz Oshiro E, Fernandez Pérez C, Galante Romo
I, Corral Rosillo J, Prieto Nogal S, et al. Long-term outcomes after
robotic sacrocolpopexy in pelvic organ prolapse: prospective anal-
ysis. Urol Int. 2011;86:414–8.
61. Shimko MS, Umbreit EC, Chow GK, Elliott DS. Long-term out-
comes of robotic-assisted laparoscopic sacrocolpopexy with a min-
imum of three years follow-up. J Robot Surg. 2011;5:175–80.
62. Geller EJ, Parnell BA, Dunivan GC. Robotic vs abdominal
sacrocolpopexy: 44-month pelvic floor outcomes. Urology.
2012;79:532–6.
63. Göçmen A, Sanl ıkan F, Uçar MG. Robotic-assis ted
sacrocolpopexy/sacrocervicopexy repair of pelvic organ prolapse:
initial experience. Arch Gynecol Obstet. 2012;285:683–8.
64. Mourik SL, Martens JE, Aktas M. Uterine preservation in pelvic
organ prolapse using robot assisted laparoscopic sacrohysteropexy:
quality of life and technique. Eur J Obstet Gynecol Reprod Biol.
2012;165:122–7.
65. Siddiqui NY, Geller EJ, Visco AG. Symptomatic and anatomic 1-
year outcomes after robotic and abdominal sacrocolpopexy. Am J
Obstet Gynecol. 2012;206:435.e1–5.
66. Belsante M, Murray S, Dillon B, Zimmern P. Mid term outcome of
robotic mesh sacrocolpopexy. Can J Urol. 2013;20:6656–61.
67. Louis-Sylvestre C, Herry M. Robotic-assisted laparoscopic
sacrocolpopexy for stage III pelvic organ prolapse. Int
Urogynecol J. 2013;24:731–3.
68. Salamon CG, Lewis C, Priestley J, Gurshumov E, Culligan PJ.
Prospective study of an ultra-lightweight polypropylene Y mesh
for robotic sacrocolpopexy. Int Urogynecol J. 2013;24:1371–5.
69. Barboglio PG, Toler AJW, Triaca V. Robotic sacrocolpopexy for
the management of pelvic organ prolapse: a review of midterm
surgical and quality of life outcomes. Female Pelvic Med
Reconstr Surg. 2014;20:38–43.
70. Borahay MA, Oge T, Walsh TM, Patel PR, Rodriguez AM, Kilic
GS. Outcomes of robotic sacrocolpopexy using barbed delayed
absorbable sutures. J Minim Invasive Gynecol. 2014;21:412–6.
71. Culligan PJ, Gurshumov E, Lewis C, Priestley JL, Komar J, Shah
N, et al. Subjective and objective results 1 year after robotic
sacrocolpopexy using a lightweight Y-mesh. Int Urogynecol J.
2014;25:731–5.
72. Ploumidis A, Spinoit A-F, De Naeyer G, Schatteman P, Gan M,
Ficarra V, et al. Robot-assisted sacrocolpopexy for pelvic organ
prolapse: surgical technique and outcomes at a single high-
volume institution. Eur Urol. 2014;65:138–45.
73. Jambusaria LH, Murphy M, Lucente VR. One-year functional and
anatomic outcomes of robotic sacrocolpopexy versus vaginal
extraperitoneal colpopexy with mesh. Female Pelvic Med
Reconstr Surg. 2015;21:87–92.
74. Linder BJ, Chow GK, Elliott DS. Long-term quality of life out-
comes and retreatment rates after robotic sacrocolpopexy. Int J
Urol. 2015;22:1155–8.
75. Myers EM, Siff L, Osmundsen B, Geller E, Matthews CA.
Differences in recurrent prolapse at 1 year after total vs
supracervical hysterectomy and robotic sacrocolpopexy. Int
Urogynecol J. 2015;26:585–9.
76. Prendergast E, Silver H, Johnson LL, Simon M, Feinglass J, Kielb
S, et al. Anatomic outcomes of robotic assisted Supracervical hys-
terectomy and concurrent Sacrocolpopexy at a tertiary care institu-
tion at initial adaptation of the procedure. Female Pelvic Med
Reconstr Surg. 2016;22:29–32.
77. Linder BJ, Anand M, Klingele CJ, Trabuco EC, Gebhart JB,
Occhino JA. Outcomes of robotic sacrocolpopexy using only ab-
sorbable suture for mesh fixation. Female Pelvic Med Reconstr
Surg. 2017;23:13–6.
78. Sullivan ES, Longaker CJ, Lee PY. Total pelvic mesh repair: a ten-
year experience. Dis Colon Rectum. 2001;44:857–63.
79. Lim M, Sagar PM, Gonsalves S, Thekkinkattil D, Landon C.
Surgical management of pelvic organ prolapse in females: function-
al outcome of mesh sacrocolpopexy and rectopexy as a combined
procedure. Dis Colon Rectum. 2007;50:1412–21.
80. Wu JS. Rectal prolapse: a historical perspective. Curr Probl Surg.
2009;46:602–716.
81. Bako A, Dhar R. Review of synthetic mesh-related complications
in pelvic floor reconstructive surgery. Int Urogynecol J. 2009;20:
103–11.
82. Gutman R, Maher C. Uterine-preserving POP surgery. Int
Urogynecol J. 2013;24:1803–13.
83. Trilling B, Martin G, Faucheron J-L. Mesh erosion after laparo-
scopic rectopexy: a benign complication? Color Dis. 2014;16:
832–3.
84. Deffieux X, Letouzey V, Savary D, Sentilhes L, Agostini A, Mares
P, et al. Prevention of complications related to the use of prosthetic
meshes in prolapse surgery: guidelines for clinical practice. Eur J
Obstet Gynecol Reprod Biol. 2012;165:170–80.
85. Evans C, Stevenson AR, Sileri P, Mercer-Jones MA, Dixon AR,
Cunningham C, et al. A multicenter collaboration to assess the
safety of laparoscopic ventral Rectopexy. Dis Colon Rectum.
2015;58:799–807.
86. Earle DB, Mark LA. Prosthetic material in inguinal hernia repair:
how do I choose? Surg Clin North Am. 2008;88:179–201.
87. Smart NJ, Pathak S, Boorman P, Daniels IR. Synthetic or biological
mesh use in laparoscopic ventral mesh rectopexy—a systematic
review. Color Dis. 2013;15:650–4.
88. Ogilvie JW, Stevenson ARL, Powar M. Case-matched series of a
non-cross-linked biologic versus non-absorbable mesh in laparo-
scopic ventral rectopexy. Int J Colorectal Dis. 2014;29:1477–83.
89. Tate SB, Blackwell L, Lorenz DJ, Steptoe MM, Culligan PJ.
Randomized trial of fascia lata and polypropylene mesh for abdom-
inal sacrocolpopexy: 5-year follow-up. Int Urogynecol J. 2011;22:
137–43.
90. Culligan PJ, Blackwell L, Goldsmith LJ, C a G, Rogers A, Heit
MH. A randomized controlled trial comparing fascia lata and syn-
thetic mesh for sacral colpopexy. Obstet Gynecol. 2005;106:29–37.
91. Badrek-Amoudi AH, Roe T, Mabey K, Carter H, Mills A, Dixon
AR. Laparoscopic ventral mesh rectopexy in the management of
solitary rectal ulcer syndrome: a cause for optimism? Colorectal
Dis. 2013;15:575–81.
Publisher’s note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
1433Int Urogynecol J (2020) 31:1423–1433
